SUMMARY A liposomal delivery system was developed in an attempt to prolong ocular levels of 5-fluorouracil for glaucoma filtering surgery. The pharmacokinetics of the 5-fluorouracil liposomal delivery system were studied in normal pigmented rabbits with 5-fluorouracil labelled with carbon-14 (C-14). 14C 5-fluorouracil was incorporated into the liposomes at a concentration of 10 g/l and injected subconjunctivally in doses of 5 and 10 mg. Concentrations of 5-fluorouracil were assayed at 10 time intervals from 0-5 to 96 hours in cornea, sclera, and conjunctiva and at six time intervals from 0-5 to 12 hours in aqueous. Two peak concentrations were noted at approximately one and eight hours, with measurable levels present at 96 hours. This study demonstrates the ability of this liposomal delivery system to prolong levels of 5-fluorouracial in normal pigmented rabbits.
5-Fluorouracil, a synthetic pyrimidine, has been shown to decrease fibroblast proliferation in vitro' and has been used clinically to treat proliferative vitreoretinopathy2 and prevent the closure of conjunctival filtering blebs.34 In preliminary studies 5-fluorouracil improved the final surgical outcome. Though various subconjunctival and intravitreal doses of 5-fluorouracil have been used, all have required frequent repetitive injections because of the short half-life of ocular 5-fluorouracil. These injections cause discomfort and inconvenience to the patient and carry the risk of haemorrhage, infection, conjunctival scarring, ocular perforation, and additional postoperative inflammation. The Dutch Belt pigmented rabbits (1.5-2-5 kg) were anaesthetised with a 0-7 ml intramuscular injection of ketamine (100 g/l) and acepromazine (1 g/l). The liposomal 5-fluorouracil was injected under the inferior bulbar conjunctiva with a 27 gauge needle. 5 mg (0-5 ml) and 10 mg (1-0 ml) of liposomal 5- hours) for aqueous. Two rabbits were used at each time interval except at 72 and 96 hours, when only one rabbit was employed. At the specified time interval each rabbit was reanaesthetised with a 0*7 ml intramuscular injection of ketamine (100 g/l) and acepromazine (1 g/l). An aqueous sample of 0* 15 ml was obtained from the anterior chamber through a 30 gauge needle. Two limbal conjunctival specimens were excised, one overlying and the other 180°from the liposomal 5-fluorouracil injection. Each rabbit was killed with a 3 0 ml intracardiac injection of euthanasia solution (Beuthanasia). After immediate enucleation the eyes were rinsed of overlying blood with normal saline and the specimens obtained. The sclera underlying the injection site was excised with a No. 15 Bard Parker blade. Central corneal or whole corneal specimens were removed with corneoscleral scissors. All specimens and five samples of carbon-14 labelled liopsomal 5-fluorouracil were placed in scintillation vials and weighed with an analytical balance. All solid tissue specimens were dried prior to weighing. 50 gl of normal saline were added to each scintillation vial, allowance being made for rehydration of the tissue specimens. 1 ml of tissue solubiliser (Protosol) was added to each vial. When digested the solutions were neutralised with acetic acid, and 10-0 ml of scintillation fluid was added to each vial. The radioactivity of all the samples was recorded in a liquid scintillation counter. Ten control vials containing appropriate quantities of the reagents used were recorded to assess background radioactivity.
Results
The average concentration of 5-fluorouracil in the six ocular tissues studied after a 5 mg injection of liposomal 5- 24 junctival injection89 or by topical drops5 suggest that DURS a lower peak concentration was obtained in aqueous ofthe 5-fluorouracil levels (Table 3 ) and in all ocular tissues examined except for , and aqueousfollowing a the conjunctiva overlying the liposomal injection site The two peak concentrations (Table 4) . with a biphasic release ofthe
On the other hand high levels of 5-fluorouracil in almatrix.
the sclera and conjunctiva located at the injection site were obtained throughout the 96 hours studied. The combination of lower peak concentrations of 5-ation of 5-fluorouracil in fluorouracil in the cornea and aqueous and high y this concentration was concentrations of 5-fluorouracil surrounding the subea, and sclera 96 hours conjunctival injection site may have important in aqueous for more than clinical implications for the efficacy of this delivery ntation (Fig. 1) system.
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